Enzon Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ENZN
CUSIP
293904108
All holders as of
Q1 2020
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 293904108 since 12/18/2024, newest first.

Filer % of Class Filed
Carl C Icahn 13D/A Amendment 19
93.7% 3/27/2026
Event 3/25/2026
Carl C Icahn 13D/A Amendment 18
48.6% 1/30/2026
Event 1/30/2026
Carl C Icahn 13D/A Amendment 17
48.6% 10/24/2025
Event 10/24/2025
Carl C Icahn 13D/A Amendment 16
48.6% 6/23/2025
Event 6/20/2025
Carl C Icahn 13D/A Amendment 15
48.6% 12/19/2024
Event 12/19/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q1 1 6.65 k $1.00 k
2019 Q2 1 49.1 k $13.0 k
2019 Q1 1 49.1 k $11.0 k
2018 Q4 1 77.1 k $19.0 k
2018 Q3 1 64.9 k $16.0 k
2018 Q2 1 39.7 k $10.0 k
2018 Q1 1 39.7 k $10.0 k
2017 Q4 1 39.7 k $11.0 k
2017 Q3 1 41.9 k $10.0 k
2017 Q2 1 51.3 k $19.0 k
2017 Q1 2 53.3 k $12.5 k
2016 Q4 2 53.3 k $19.7 k
2016 Q3 4 111 k $41.7 k
2016 Q2 10 499 k $202 k
2016 Q1 39 17.3 M $8.11 M
2015 Q4 48 18.5 M $12.6 M
2015 Q3 52 18.8 M $18.3 M
2015 Q2 57 19.6 M $23.5 M
2015 Q1 52 19.3 M $20.4 M
2014 Q4 56 19.3 M $21.0 M
2014 Q3 65 23.0 M $24.9 M
2014 Q2 68 22.6 M $23.5 M
2014 Q1 76 27.1 M $27.9 M